The Food and Drug Administration (FDA) has announced a public workshop, "Evolving Role of Artificial Intelligence in Radiological Imaging," scheduled for Feb. 25, 2020 from 8:00 a.m. to 5:30 p.m. (EST) and Feb. 26, 2020 from 9:00 a.m. to 4:30 p.m. (EST) at National Institutes of Health (NIH) main campus in Bethesda, MD. The general sessions of the workshop will be webcasted, and the link will be posted on the website after the workshop.
Through this workshop, FDA is seeking to engage with stakeholders to explore benefits and risks of these evolving applications of AI in radiology. As the benefit-risk profile changes, it is critical to adapt the methods used to evaluate and characterize their performance. In this workshop, FDA is also seeking innovative and consistent ways to leverage existing methods and to develop new methods for validation of these AI-based algorithms and explore opportunities for stakeholder collaboration in these efforts.
The preliminary topics include:
February 25, 2020
· Radiological AI Device Regulation and Industry Perspectives
· Emerging Trends in Radiological AI Software - Exploring Benefits and Risks
· Emerging Trends in Radiological AI Software – Discussion Panel
· Evaluation of AI Software for Radiological Applications
· Evaluation of AI Software for Radiological Applications- Discussion Panel
February 26, 2020
· AI-Guided Image Acquisition
· AI-Guided Image Acquisition – Discussion Panel
· Innovation and Future Directions for FDA Regulation of Imaging Devices Containing AI Software
· Regulation of AI Imaging Devices – Discussion Panel
Registration is free and open until Feb. 12, 2020 at 4:00 p.m. Early registration is recommended because seating is limited.
